Compare OVLY & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OVLY | XGN |
|---|---|---|
| Founded | 1990 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 219.0M | 253.9M |
| IPO Year | N/A | 2019 |
| Metric | OVLY | XGN |
|---|---|---|
| Price | $27.75 | $7.06 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | 8.4K | ★ 345.7K |
| Earning Date | 01-23-2026 | 11-04-2025 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.84 | N/A |
| Revenue | ★ $79,783,000.00 | $63,599,000.00 |
| Revenue This Year | N/A | $22.15 |
| Revenue Next Year | N/A | $15.26 |
| P/E Ratio | $9.74 | ★ N/A |
| Revenue Growth | 2.98 | ★ 14.08 |
| 52 Week Low | $22.70 | $2.67 |
| 52 Week High | $32.24 | $12.23 |
| Indicator | OVLY | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 26.54 |
| Support Level | $27.66 | $7.01 |
| Resistance Level | $28.25 | $7.60 |
| Average True Range (ATR) | 0.45 | 0.35 |
| MACD | -0.04 | 0.01 |
| Stochastic Oscillator | 68.28 | 5.67 |
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.